SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Nile Therapeutics, Inc. Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint